New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 1 diabetes: a randomized, phase 3a, open-label clinical trial (EDITION 4) - Home, P D; Bergenstal, R M; Bolli, G B (Diabetes Care, 2015)